Istituto Europeo Di Oncologia S.r.l.

Research activity includes women at elevated risk of breast cancer, including carriers of pathogenic variants in BRCA1, BRCA2, PALB2, ATM, CHEK2, CDH1, RAD51C, and RAD51D, as well as women with risk assessed through established predictive models and those with prior breast intraepithelial neoplasia.

• Low-dose tamoxifen
• Lifestyle intervention and dietary modification
• Breast cancer risk assessment

The clinical focus extends to symptom-linked prevention strategies and hormonal risk modulation in women under surveillance for hereditary or acquired breast cancer risk.